Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)

Colorectal cancer patients with ≤10 unresectable metastases were treated with single-fraction sub-ablative radiotherapy in addition to standard of care systemic therapy in a single-arm, open-label, multicenter, pilot study (SIRIUS) to assess feasibility and safety. Results indicate that radiotherapy combined with systemic therapy is feasible and safe in this population.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Radiation Oncology
Published
2024-10-06
DOI
https://doi.org/10.1016/j.ctro.2024.100874
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)

Manon N.G.J.A. Braat, Joyce M. van Dodewaard-de Jong, Jacques Otten, Gert J. Meijer et al.
2 links
Clinical and Translational Radiation Oncology
Hepatocellular Carcinoma Treatment and Prognosis
article

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)

Manon N.G.J.A. Braat, Joyce M. van Dodewaard-de Jong, Jacques Otten, Gert J. Meijer, Koen Zwart, Cornelis J.A. Punt, Guus Martinus Bol, Jeanine M.L. Roodhart, Remond J.A. Fijneman, J.J.W. Lagendijk, Anne M. May, Tanja Oostergo, M. Intven, Frederieke H. van der Baan, Dania Al‐Toma, Maartje Los, M. Koopman
article en

Abstract

Colorectal cancer patients with ≤10 unresectable metastases were treated with single-fraction sub-ablative radiotherapy in addition to standard of care systemic therapy in a single-arm, open-label, multicenter, pilot study (SIRIUS) to assess feasibility and safety. Results indicate that radiotherapy combined with systemic therapy is feasible and safe in this population.

Clinical and Translational Radiation OncologyVol. 49
Utrecht University (NL), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), St. Antonius Ziekenhuis (NL), Diakonessenhuis hospital (NL), Meander Medisch Centrum (NL)
Good health and well-being
Openalex Percentile: Top 72%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.